One area that rarely gets discussed enough in the peptide space is storage. Most people understandably focus on the product itself, but the way products are stored, handled, rotated, and prepared for dispatch plays a huge role in overall consistency…
Recently, we have become aware of a number of unrelated websites and social media accounts using similar branding, names, store layouts, or product descriptions that may appear connected to the Bluewell Peptides brand. This includes websites and social media accounts…
As we move into Q2, the team at Bluewell Peptides is excited to share several important developments that reflect our long-term commitment to supporting the research community with high-quality compounds, transparent quality control, and reliable supply. Over the past months…
If you’ve spent any time in peptide research communities, you’ve probably been warned: Don’t shake the vial. Store it exactly at 2-8°C. Use it within 48 hours of reconstitution or it’s garbage. But here’s the thing, when you talk to…
In peptide research, consistency is not a “nice to have”. It is fundamental to reliability, repeatability, and data integrity. While purity percentages often receive the most attention, batch consistency plays an equally important role in ensuring that research materials behave…
Proper peptide storage is essential for maintaining molecular integrity, stability, and reliability over time. Whether peptides are stored in their lyophilized (freeze-dried) form or reconstituted into solution, incorrect handling can lead to degradation, oxidation, or loss of potency. This guide…
As the year comes to a close, we wanted to take a step back and reflect on what has defined peptide research over the past 12 months. Using a combination of internal interest data, researcher enquiries, and broader global research…
Welcome back to the Bluewell Peptides Weekly Roundup, your trusted update for research insights, peptide industry developments, and regulatory news. This week, we cover the recent MHRA enforcement update regarding unlicensed injectable products, highlight the continued growth of multi-peptide blends…
Overview A recent MHRA investigation exposed a large-scale operation producing and distributing unlicensed injectable weight-loss medicines, including products falsely labelled as experimental peptide compounds. These items were marketed for human use and filled into pre-loaded pens. This activity was illegal,…
Welcome back to the Bluewell Peptides Weekly Roundup, your regular update covering common research questions, emerging studies, and trends we’re seeing across the peptide research space. Each week we answer real questions from researchers, highlight notable developments, and share insights…
